Medical Research
Senator Markey is a leader in the fight to increase funding for the National Institutes of Health, the world’s preeminent medical research institution and our nation’s best hope for finding cures, improving treatments, and gaining a better understanding of the complex causes of diseases that affect millions of Americans. Last year, he was joined by 117 of his Democratic colleagues in requesting that Congressional appropriators provide the NIH with $32 billion for FY 2012. He believes this level of funding is necessary in order for NIH to sustain its mission of improving health through medical science breakthroughs and maintaining international leadership in science and biomedical research.
- Senator Markey, Rep. Neal Join Federal, State and Local Leaders in Call to Action on Heroin and Prescription Drug Overdose Crisis in Western Mass. Posted on 03/07/14
- Senator Markey, Rep. Neal to Discuss Heroin & Prescription Drug Abuse Crisis in Western Mass. Posted on 03/06/14
- Markey Calls for Expanding Availability of Treatment to Help First Responders Prevent Opiate Use and Abuse Posted on 02/11/14
- Senator Markey Introduces Resolution Declaring September Brain Aneurysm Month Posted on 02/11/14
-
SENATORS URGE SWIFT REVIEW OF FDA RULE TO REGULATE THE MANUFACTURING, SALE, AND MARKETING OF E-CIGARETTES Posted on 12/20/13
As tobacco products like electronic cigarettes and flavored cigars continue to grow in popularity and increase nicotine addiction and tobacco use among young people, U.S. Senators Dick Durbin (D-IL), Sherrod Brown (D-OH), Barbara Boxer (D-CA), and Ed Markey (D-MA) today called on the Office of Management and Budget (OMB) to promptly complete its review of a proposed rule from the U.S. Food and Drug Administration (FDA), which would expand the FDA’s regulatory authority over tobacco products.
Read More -
Markey Commends FDA Action on Triclosan Posted on 12/16/13
Senator Edward J. Markey (D-Mass.) released the following statement after the Food and Drug Administration (FDA) today issued a proposed rule to require manufacturers of antibacterial hand soaps and body washes to demonstrate that these products are safe for long-term daily use and more effective than plain soap and water in preventing illness.
Read More - Markey Applauds Passage of Bipartisan Compounding Pharmacy Legislation Posted on 11/18/13